Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Bloomer

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Oncology Research|October 9, 2001
4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamineM V Papadopoulou, M Ji, M K Rao, et al.
Oncology Research|January 1, 1994
9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1M V Papadopoulou, H S Rosenzweig, M Doddi, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|May 20, 1998
Tin shielding thicknesses for electronsS Guru Prasad, K Parthasaradhi, W H Al-Najjar, et al.
Nuclear Medicine and Biology|January 1, 1993
A technique to prepare boronated B72.3 monoclonal antibody for boron neutron capture therapyG N Ranadive, H S Rosenzweig, M W Epperly, et al.
Archives of Gynecology and Obstetrics|January 1, 1989
Diminished corticosterone levels in nude mice implanted with MCF-7 or ZR-75-1 human breast tumor cellsS Lehrer, E Diamond, H K Song, et al.
AJR. American Journal of Roentgenology|October 1, 1976
Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancerP H Sugarbaker, W D Bloomer, E D Corbett, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1992
Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compoundsM V Papadopoulou, M W Epperly, D S Shields, et al.
Cancer|September 1, 1978
Carcinoembryonic antigen (CEA): its role as a monitor of radiation therapy for colorectal cancerP H Sugarbaker, W D Bloomer, E D Corbett, et al.
Strahlentherapie|December 1, 1984
Therapeutic applications of Auger and alpha emitting radionuclidesW D Bloomer, W H McLaughlin, S J Adelstein, et al.
Clinical & Experimental Metastasis|May 1, 1993
Enhancement of pulmonary metastasis formation and gamma-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitroJ A Prezioso, N Wang, L Duty, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Oncology Research|October 9, 2001
4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamineM V Papadopoulou, M Ji, M K Rao, et al.
Oncology Research|January 1, 1994
9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1M V Papadopoulou, H S Rosenzweig, M Doddi, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|May 20, 1998
Tin shielding thicknesses for electronsS Guru Prasad, K Parthasaradhi, W H Al-Najjar, et al.
Nuclear Medicine and Biology|January 1, 1993
A technique to prepare boronated B72.3 monoclonal antibody for boron neutron capture therapyG N Ranadive, H S Rosenzweig, M W Epperly, et al.
Archives of Gynecology and Obstetrics|January 1, 1989
Diminished corticosterone levels in nude mice implanted with MCF-7 or ZR-75-1 human breast tumor cellsS Lehrer, E Diamond, H K Song, et al.
AJR. American Journal of Roentgenology|October 1, 1976
Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancerP H Sugarbaker, W D Bloomer, E D Corbett, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1992
Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compoundsM V Papadopoulou, M W Epperly, D S Shields, et al.
Cancer|September 1, 1978
Carcinoembryonic antigen (CEA): its role as a monitor of radiation therapy for colorectal cancerP H Sugarbaker, W D Bloomer, E D Corbett, et al.
Strahlentherapie|December 1, 1984
Therapeutic applications of Auger and alpha emitting radionuclidesW D Bloomer, W H McLaughlin, S J Adelstein, et al.
Clinical & Experimental Metastasis|May 1, 1993
Enhancement of pulmonary metastasis formation and gamma-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitroJ A Prezioso, N Wang, L Duty, et al.
Pageof 11